The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Ketamine and Magnesium for Refractory Neuropathic Pain: A Randomized, Double-blind, Crossover Trial
Abstract
Background: Ketamine is often used for the management of refractory chronic pain. There is, however, a paucity of trials exploring its analgesic effect several weeks after intravenous administration or in association with magnesium. The authors hypothesized that ketamine in neuropathic pain may provide pain relief and cognitive–emotional benefit versus placebo and that a combination with magnesium may have an additive effect for 5 weeks. Methods: A randomized, double-blind, crossover, placebo-controlled study (NCT02467517) included 20 patients with neuropathic pain. Each ketamine-naïve patient received one infusion every 35 days in a random order: ketamine (0.5 mg/kg)/placebo or ketamine (0.5 mg/kg)/magnesium sulfate (3g) or placebo/placebo. The primary endpoint was the area under the curve of daily pain intensity for a period of 35 days after infusion. Secondary endpoints included pain (at 7, 15, 21 and 28 days) and health-related, emotional, sleep, and quality of life questionnaires. Results: Daily pain intensity was not significantly different between the three groups (n = 20) over 35 days (mean area under the curve = 185 ± 100, 196 ± 92, and 187 ± 90 pain score-days for ketamine, ketamine/magnesium, and placebo, respectively, P = 0.296). The effect size of the main endpoint was −0.2 (95% CI [−0.6 to 0.3]; P = 0.425) for ketamine versus placebo, 0.2 (95% CI [−0.3 to 0.6]; P = 0.445) for placebo versus ketamine/magnesium and -0.4 (95% CI [−0.8 to 0.1]; P = 0.119) for ketamine versus ketamine/magnesium. There were no significant differences in emotional, sleep, and quality of life measures. During placebo, ketamine, and ketamine/magnesium infusions, 10%, 20%, and 35% of patients respectively reported at least one adverse event. Conclusions: The results of this trial in neuropathic pain refuted the hypothesis that ketamine provided pain relief at 5 weeks and cognitive–emotional benefit versus placebo and that a combination with magnesium had any additional analgesic effect. Editor’s Perspective: What We Already Know about This Topic: What This Article Tells Us That Is New:
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a double-blind, randomized, controlled trial of 20 individuals with neuropathic pain, ketamine had no analgesic effects at five weeks post-infusion”
From Ketamine in neuropsychiatric disorders: an update (2024) · cites this paper as [131]
In the citing paper
“suggesting that it may work more acutely [131]”
From Ketamine in neuropsychiatric disorders: an update (2024) · cites this paper as [131]
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research
Buysse, D. J., Reynolds, C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90047-4 · Cited by 35,234
Validating the SF-36 health survey questionnaire: new outcome measure for primary care.
Brazier, J. E., Harper, R., Jones, N. M., O'Cathain, A., Thomas, K. J., Usherwood, T., & Westlake, L. (1992) · BMJ · doi:10.1136/bmj.305.6846.160 · Cited by 4,653
Linear Mixed Models for Longitudinal Data
Verbeke, G. (1997) · Lecture Notes in Statistics · doi:10.1007/978-1-4612-2294-1_3 · Cited by 3,506
Bouhassira, D., Attal, N., Alchaar, H., Boureau, F., Brochet, B., Bruxelle, J., Cunin, G., Fermanian, J., Ginies, P., Grun-Overdyking, A., et al. (2005) · Pain · doi:10.1016/j.pain.2004.12.010 · Cited by 2,741
Validation of the Brief Pain Inventory for chronic nonmalignant pain
Tan, G., Jensen, M. P., Thornby, J. I., & Shanti, B. F. (2004) · The Journal of Pain · doi:10.1016/j.jpain.2003.12.005 · Cited by 1,416
Development and validation of the Neuropathic Pain Symptom Inventory
Bouhassira, D., Attal, N., Fermanian, J., Alchaar, H., Gautron, M., Masquelier, E., Rostaing, S., Lanteri-Minet, M., Collin, E., Grisart, J., et al. (2004) · Pain · doi:10.1016/j.pain.2003.12.024 · Cited by 1,329
The French SF-36 Health Survey
Leplège, A., Ecosse, E., Verdier, A., & Perneger, T. V. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00093-6 · Cited by 688
Schwenk, E. S., Viscusi, E. R., Buvanendran, A., Hurley, R. W., Wasan, A. D., Narouze, S., Bhatia, A., Davis, F. N., Hooten, W. M., & Cohen, S. P. (2018) · Regional Anesthesia and Pain Medicine · doi:10.1097/aap.0000000000000806 · Cited by 584
The McGill Pain Questionnaire: From Description to Measurement
Melzack, R., & Raja, S. N. (2005) · Anesthesiology · doi:10.1097/00000542-200507000-00028 · Cited by 484
Research works printed but not linked: 1
- Pickering, 2018, Ketamine and chronic pain: A narrative review of its efficacy and safety. Article in French., Thérapie., 73, 529
Cited by
Advances and challenges in neuropathic pain: a narrative review and future directions
Attal, N., Bouhassira, D., & Colvin, L. (2023) · British Journal of Anaesthesia · doi:10.1016/j.bja.2023.04.021 · Cited by 171
Ketamine in neuropsychiatric disorders: an update
Johnston, J. N., Kadriu, B., Kraus, C., Henter, I. D., & Zarate, C. A. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-023-01632-1 · Cited by 108
Balanaser, M., Carley, M. E., Baron, R., Finnerup, N. B., Moore, A., Rowbotham, M. C., Chaparro, L. E., & Gilron, I. (2022) · Pain · doi:10.1097/j.pain.0000000000002688 · Cited by 116
Combination Therapy for Neuropathic Pain: A Review of Recent Evidence
Afonso, A. S., Carnaval, T., & Videla, S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163533 · Cited by 61
Management of pain using magnesium sulphate: a narrative review
Soleimanpour, H., Imani, F., Dolati, S., Soleimanpour, M., & Shahsavarinia, K. (2022) · Postgraduate Medicine · doi:10.1080/00325481.2022.2035092 · Cited by 52
Metadata
- Authors
- Pickering, G., Pereira, B., Morel, V., Corriger, A., Giron, F., Marcaillou, F., Bidar-Beauvallot, A., Chandeze, E., Lambert, C., Bernard, L., & Delage, N.
- Affiliations
- Inserm (FR)
- ORCID
- Venue
- Anesthesiology
- Published
- 2020-05-06
- Volume
- 133
- Issue
- 1
- Pages
- 154-164
- ISSN
- 0003-3022 (ISSN-L)
- 1528-1175
- OpenAlex
- W3021889050
- Cited by
- 69
- References
- 51
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 4 · 2023: 14 · 2022: 12 · 2021: 19 · 2020: 3
- FWCI
- 7.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Anesthesiology (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Treatment
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Pain Management
- Keywords
- ketamine, magnesium sulfate, neuropathic pain, refractory chronic pain, analgesic effect, combination therapy, pain intensity, quality of life, sleep, emotional well-being, adverse events, long-term pain management
- MeSH terms
- Adult, Aged, Cognition, Double-Blind Method, Drug Therapy, Combination, Emotions, Female, Humans, Infusions, Intravenous, Ketamine, Magnesium Sulfate, Male, Middle Aged, Neuralgia, Pain Measurement, Treatment Outcome, Cross-Over Studies, Excitatory Amino Acid Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ketamine and Magnesium for Refractory Neuropathic Pain: A Randomized, Double-blind, Crossover Trial. https://app.cochat.ai/papers/10.1097/aln.0000000000003345
- The paper
- Pickering, G., Pereira, B., Morel, V., Corriger, A., Giron, F., Marcaillou, F., Bidar-Beauvallot, A., Chandeze, E., Lambert, C., Bernard, L., & Delage, N. (2020). Ketamine and Magnesium for Refractory Neuropathic Pain: A Randomized, Double-blind, Crossover Trial. Anesthesiology. https://doi.org/10.1097/aln.0000000000003345
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.